Clearmind Medicine to Partner with Microdose for Psychedelic Capital: Mar 2022 Today, Thursday, March 24th
TORONTO, March 24, 2022 -- Clearmind Medicine Inc. , a psychedelic medicine biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread... | March 24, 2022
United States Mark Haden Adi Zuloff Shani Vp Business Development Clearmind Medicine Inc Frankfurt Stock Exchange
Source: marketscreener.com